Novel Drug Therapies for the Treatment of Crohn's Disease

Novel Oral Drug Candidate Reduces Disease Activity and Lowers ...

With support and funding from the Crohn's & Colitis Foundation, researchers designed this drug to inhibit the function of an enzyme called ...

Injectable Therapy Shows Promise in Treating Crohn's Disease

Depending on disease severity, current treatment options for inflammatory bowel diseases (IBDs) range from oral medications to highly invasive ...

Modern Advanced Therapies for Inflammatory Bowel Diseases

This inhibition is variably selective: tofacitinib, which was Food and Drug Administration (FDA)-approved to treat ulcerative colitis (UC) in ...

Potential new drug therapy for Crohn's disease | ScienceDaily

Potential new drug therapy for Crohn's disease ... Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive ...

P098 Novel drug candidate for the treatment of Inflammatory Bowel ...

... therapies for IBD. NEXEL's novel protein NP-011, targeting αVβ3 and αVβ5 integrins and phosphatidylserine, has shown anti-inflammatory and anti-fibrotic ...

Development of a Novel Drug Delivery System to Deliver Drugs ...

Despite recent drug approvals for the treatment of inflammatory bowel diseases (IBDs), there remains a high unmet need for new technologies ...

The Medical Minute: Crohn's disease has no cure, but new ...

The Medical Minute: Crohn's disease has no cure, but new treatments bring hope · What are the symptoms? · How is it diagnosed? · What is available ...

EntyvioTM: A New Treatment for Ulcerative Colitis & Crohn's Disease

Overall, EntyvioTM is a promising treatment option for patients that have not been able to control their symptoms using traditional therapies.

Why I'm Hopeful About Treating Crohn's Disease - WebMD

I'm also excited that a medication that blocks IL-23 has been approved for treating moderate to severe Crohn's in adults. Risankizumab-rzaa ( ...

Weighing the new approaches to treating Crohn's and ulcerative colitis

Tofacitinib has been approved for the treatment of moderate to severe UC, and is being investigated in CD. Upadacitinib was shown to have high ...

New Drug Therapies on the Horizon for IBD - Karger Publishers

Several anti-TNF-α agents are currently used to treat Crohn's disease and ulcerative colitis. Although these molecules have dramatically ...

Exploring the Newest Crohn's Disease Medications (2024)

The introduction of Risankizumab-rzaa (Skyrizi) and Ustekinumab-auub (Wezlana) represents a significant milestone in Crohn's disease treatment, offering new ...

Study Finds Potential New Drug Therapy for Crohn's Disease

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects ...

Medication for Inflammatory Bowel Disease - NYU Langone Health

Anti-integrin therapy may be prescribed for people with severe IBD whose symptoms have not responded to other medications. This therapy prevents inflammation- ...

FDA approves first oral treatment for moderately to severely active ...

FDA has approved Rinvoq (upadacitinib) for adults with moderately to severely active Crohn's disease who have had an inadequate response or ...

Medications for Crohn's Disease: Types and Examples

These include drugs such as aminosalicylates, steroids, and antibiotics. Other novel treatments approved in recent years include biologics and ...

Medicines on the horizon - Crohn's & Colitis UK

Information on new treatments being tested for Crohn's or Colitis (the two main forms of Inflammatory Bowel Disease or IBD), including late-stage research ...

New drug for Crohn's disease targets RNA | Science | AAAS

Taking an approach with a long and checkered history, a new drug seems to alleviate the symptoms of Crohn's disease, a condition that can ...

Crohn Disease Medication - Medscape Reference

For colon and small bowel inflammation, anti-inflammatory drugs or antibiotics are helpful. Neither sulfasalazine nor balsalazide alleviates small bowel disease ...

Researchers Identify Promising Compound for IBD Treatment

... Drug Discovery has synthesized and tested a new class of gut-restricted oral therapies that shows promise in treating inflammatory bowel disease